Literature DB >> 26770345

Efficiency of muscle strength training on motor function in patients with coronary artery disease: a meta-analysis.

Yu-Jie Yang1, Xiao-Hua He2, Hai-Ying Guo1, Xue-Qiang Wang3, Yi Zhu4.   

Abstract

BACKGROUND: Existing literature has shown that patients with coronary artery disease (CAD) can benefit greatly from the strength training; therefore, the strength training should play a more important role in cardiac rehabilitation. However, the medical community may still have conservation to apply the strength training owing to no comprehensive study so far to compare the effectiveness of the strength training to the other trainings, such as aerobic training.
OBJECTIVE: To evaluate the effect of strength training on motor function in patients with CAD.
METHODS: Published articles from the earliest date available to July 2015 were identified using electronic searches. Two reviewers selected independently relevant randomized controlled trials (RCTs) investigating exercise program with strength training versus control interventions (exercise without strength training, including aerobic training and no exercise group) for the treatment of CAD patients. We examined effects of exercise with strength training versus control interventions on peak oxygen uptake (VO2peak), duration of exercise test and muscle strength. Two reviewers extracted data independently.
RESULTS: Twenty seven trials that represented 1151 participants passed the selection criteria and were evaluated for the effects of strength training in CAD patients. For improving VO2peak [SMD (95%CI) = 0.58 (0.11, 1.06)] and muscle strength [upper limb, SMD (95% CI) =0.44 (0.34, 0.55); lower limb, SMD (95% CI) =0.33 (0.16, 0.50)], exercise program with strength training were significantly more effective than one without it. But there is no significantly difference on duration of exercise test [SMD (95%CI) = 0.17 (-0.04, 0.39)] in strength training group than in control group.
CONCLUSIONS: We conclude strength training is effective in improving muscle strength and VO2peak, in CAD patients, when compared to patients with control group. Furthermore, our evaluations suggest that strength training does not compromise clinical trial completion or safety.

Entities:  

Keywords:  Coronary artery disease; meta-analysis; motor function; muscle strength training; randomized controlled trials

Year:  2015        PMID: 26770345      PMCID: PMC4694245     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  40 in total

1.  Interval and strength training in CAD patients.

Authors:  J Helgerud; T Karlsen; W Y Kim; K L Høydal; A Støylen; H Pedersen; L Brix; S Ringgaard; J Kværness; J Hoff
Journal:  Int J Sports Med       Date:  2010-11-11       Impact factor: 3.118

Review 2.  Incorporating considerations of resources use into grading recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Regina Kunz; Roman Jaeschke; Mark Helfand; Alessandro Liberati; Gunn E Vist; Holger J Schünemann
Journal:  BMJ       Date:  2008-05-24

3.  Grading quality of evidence and strength of recommendations for diagnostic tests and strategies.

Authors:  Holger J Schünemann; A Holger J Schünemann; Andrew D Oxman; Jan Brozek; Paul Glasziou; Roman Jaeschke; Gunn E Vist; John W Williams; Regina Kunz; Jonathan Craig; Victor M Montori; Patrick Bossuyt; Gordon H Guyatt
Journal:  BMJ       Date:  2008-05-17

4.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26

5.  Effects of a low-intensity dynamic-resistance training protocol using an isokinetic dynamometer on muscular strength and aerobic capacity after coronary artery bypass grafting.

Authors:  S Ghroubi; W Elleuch; L Abid; M Abdenadher; S Kammoun; M H Elleuch
Journal:  Ann Phys Rehabil Med       Date:  2012-12-07

6.  Circuit weight training in early cardiac rehabilitation.

Authors:  R M Butler; G Palmer; F J Rogers
Journal:  J Am Osteopath Assoc       Date:  1992-01

7.  Usefulness of weightlifting training in improving strength and maximal power output in coronary artery disease.

Authors:  N McCartney; R S McKelvie; D R Haslam; N L Jones
Journal:  Am J Cardiol       Date:  1991-05-01       Impact factor: 2.778

8.  Safety and efficacy of weight training soon after acute myocardial infarction.

Authors:  K J Stewart; L D McFarland; J J Weinhofer; E Cottrell; C S Brown; E P Shapiro
Journal:  J Cardiopulm Rehabil       Date:  1998 Jan-Feb       Impact factor: 2.081

9.  Effect of aerobic vs combined aerobic-strength training on 1-year, post-cardiac rehabilitation outcomes in women after a cardiac event.

Authors:  Heather M Arthur; Elizabeth Gunn; Kevin E Thorpe; Kathleen Martin Ginis; Lin Mataseje; Neil McCartney; Robert S McKelvie
Journal:  J Rehabil Med       Date:  2007-11       Impact factor: 2.912

10.  Circuit weight training in cardiac patients.

Authors:  M H Kelemen; K J Stewart; R E Gillilan; C K Ewart; S A Valenti; J D Manley; M D Kelemen
Journal:  J Am Coll Cardiol       Date:  1986-01       Impact factor: 24.094

View more
  3 in total

1.  Age-dependent changes in cardiac performance, motor function, QoL, and mental status in metoprolol-treated chronic heart failure patients.

Authors:  Qiuhong Shu; Liyong Wu; Ran Zhang; Qian Zhang; Jingjing Huang; Yong Meng
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

2.  Long-Term Enrollment in Cardiac Rehabilitation Benefits of Cardiorespiratory Fitness and Skeletal Muscle Strength in Females with Cardiovascular Disease.

Authors:  Mike Pryzbek; Maureen MacDonald; Paul Stratford; Julie Richardson; Angelica McQuarrie; Robert McKelvie; Ada Tang
Journal:  Womens Health Rep (New Rochelle)       Date:  2021-11-29

3.  Effectiveness of Metoprolol in Improving Cardiac and Motor Functions in Patients with Chronic Heart Failure: A Prospective Study.

Authors:  XiaoLiang Cheng; Min Zhu; Qing Liu; Zhenxia Feng; Yong Meng
Journal:  Drug Des Devel Ther       Date:  2020-08-25       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.